,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer ...
A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...
A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...
Patients will first be eligible to receive the drug if they have a BMI over 40 and at least three of specified weight-related ...
This article delves into the pros and cons of these drugs, addressing potential side effects (including the rare ones).
‘Fat’ jabs, ‘skinny’ jabs, ‘anti-obesity’ medications – weight-loss drugs come with many names. A favourite amongst celebs ...
The new trial aims to gather evidence of the effects of the drug tirzepatide – sold by pharmaceutical company Lily under brand name Mounjaro ...
The UK government is exploring a new initiative to help unemployed individuals return to the workforce by offering ...
Federal regulators shook up the booming weight loss drug marketplace when they ... is selling semaglutide for — starting at $200 per month compared to nearly $1,000 monthly for Ozempic.
The UK plans to test US firm Eli Lilly's weight-loss jab Mounjaro to help the burden on the national health care system. Over a quarter of UK adults suffered from obesity in 2023, according to ...